Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Ad5-nCoV Vaccine in Adults Previously Vaccinated With One Dose of Sputnik V
NCT05293223Phase 2Completed
- Sponsor
- Fundación Huésped
- Start
- Oct 2021
- Primary completion
- Nov 2022
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ad5-ncov in coronavirus disease 2019 (COVID-19), sponsored by Fundación Huésped. Started Oct 2021; status: completed.
02
Drugs
ad5-ncov
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05293223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05293223.